New York-based pet technology and wellness company Fi has initiated a voluntary recall of two specific lines of canine nutritional supplements. The recall, prompted by the discovery of potential Salmonella contamination within a raw ingredient provided by a third-party supplier, highlights the ongoing complexities of supply chain transparency in the pet health industry. While no illnesses have been officially confirmed at this time, the company is urging pet owners to immediately cease feeding these products to their animals and dispose of them securely.
Main Facts: The Scope of the Recall
The recall affects two distinct supplement products sold directly to consumers and through major e-commerce platforms, including Amazon and Chewy.com. The issue stems from an ingredient supplied to Fi’s third-party manufacturing partner. Upon learning of the potential contamination, Fi suspended production of the affected items indefinitely while a comprehensive investigation is conducted.
Affected Products
Consumers are advised to check the lot numbers on their product packaging immediately. The affected items are:
- Fi Calming Supplement for Dogs (180 g): Lot Number 26118, UPC 8 50064 80011 1.
- Fi 8-in-1 Formula Supplement for Dogs (180 g): Lot Number 26159, UPC 8 50055 11168 4.
Fi has emphasized that this is a proactive move. By notifying customers promptly, the company aims to minimize the risk of human or animal exposure. The company has explicitly instructed customers to seal the containers tightly and discard them in a secure trash receptacle to prevent accidental consumption by pets or wildlife.
Chronology of the Investigation
The sequence of events leading to the recall underscores the speed at which food safety protocols are intended to operate.
- Notification of Contamination: The process began when Fi was alerted to a potential pathogen risk associated with a raw material ingredient used in their manufacturing process.
- Manufacturing Halt: Upon receiving this information, Fi management immediately mandated a production stoppage at the facility responsible for the supplements.
- Root Cause Analysis: A forensic investigation into the supply chain was launched to isolate the contaminated batch and identify how the Salmonella entered the production stream.
- Regulatory Communication: Fi worked in coordination with the U.S. Food and Drug Administration (FDA) to finalize the logistics of the public recall announcement.
- Customer Outreach: Leveraging their direct-to-consumer database and retail partners, Fi began the notification process to ensure that owners who purchased the products online were alerted via email and platform alerts.
The company continues to monitor the situation and is working with the FDA to ensure that the source of the contamination is fully remediated before any future production resumes.
Supporting Data: Understanding Salmonella Risks
Salmonella is a genus of bacteria that can cause serious and sometimes fatal infections in both humans and animals. Understanding the nature of this pathogen is crucial for pet owners who may have handled these supplements.
Risks to Human Health
Humans are primarily at risk through cross-contamination. This can occur when an owner handles the supplement chews—which may contain dust or residue—and then touches their face or prepares food without washing their hands. Additionally, pet owners are at risk when cleaning up animal waste from pets that have ingested the contaminated product.
Symptoms in healthy individuals often include:
- Nausea and vomiting
- Abdominal cramping
- Diarrhea or bloody diarrhea
- Fever
In vulnerable populations—such as young children, the elderly, or those with compromised immune systems—Salmonella can be far more severe. In rare, advanced cases, the bacteria can enter the bloodstream and cause systemic issues, including arterial infections, endocarditis (inflammation of the heart lining), arthritis, and persistent eye or urinary tract irritation.
Risks to Canine Health
Dogs infected with Salmonella may display similar symptoms to humans, though the presentation can vary. Common clinical signs include:
- Lethargy and listlessness
- Decreased appetite
- Fever
- Persistent diarrhea (sometimes with blood)
- Vomiting and signs of abdominal pain
Crucially, it is possible for a dog to be a "silent carrier." This means a pet may show no clinical signs of illness but can still shed the bacteria in their feces, posing a constant risk of infection to other pets and the human members of their household.
Official Responses and Remediation
Fi has taken a transparent approach to the recall, providing clear channels for support. For customers seeking clarification or information regarding refunds, the company has established a dedicated support line: 1-888-434-3647. The line is staffed seven days a week, from 10:00 AM to 8:00 PM ET. Furthermore, inquiries can be directed to the company’s support team at [email protected].
The FDA, through its Center for Veterinary Medicine, provides a platform for the reporting of adverse events. Pet owners who believe their animal has suffered from illness related to this product are encouraged to complete the online Form FDA 1932a, available at www.fda.gov/reportanimalae. This data is essential for the FDA to track the scope of the contamination and the efficacy of the recall process.
Implications for the Pet Wellness Industry
This recall serves as a sobering reminder of the "invisible" risks in the pet supply chain. As the demand for high-quality, supplement-heavy canine diets grows, manufacturers are increasingly reliant on complex global supply chains. A single contaminated ingredient from a third-party provider can affect thousands of units, highlighting the necessity for rigorous, batch-level testing and stringent vendor auditing.
Supply Chain Vigilance
The incident underscores the need for "vertical integration" or stricter oversight protocols. Companies like Fi, which operate at the intersection of technology and physical health products, face unique reputational stakes. The speed of the recall is a positive indicator of modern safety standards, yet the fact that the contamination occurred at all raises questions about industry-wide standards for raw ingredient sourcing.
The Role of Consumer Awareness
For pet owners, this situation emphasizes the importance of maintaining a record of lot numbers for all pet products. When a recall is announced, the ability to quickly cross-reference a lot number can be the difference between a simple disposal and a trip to the emergency veterinary clinic. Furthermore, the FDA’s focus on the human-animal interface—reminding owners that they are at risk just as much as their pets—is a critical public health message that is often overlooked in pet food recalls.
Looking Forward
As Fi investigates the source of the Salmonella, the pet industry will likely see renewed discussions regarding the implementation of rapid-testing requirements for all raw inputs. Until the company can guarantee the integrity of its supply chain, the suspension of production remains the safest course of action.
Consumers are reminded that while the Salmonella risk is significant, it is preventable through strict hygiene practices. Always wash your hands thoroughly with soap and water after handling any pet supplement or food product, and store such items in locations inaccessible to children. If your dog is showing signs of illness, consult your veterinarian immediately and inform them of the product recall, as they may need to test specifically for Salmonella to provide the correct treatment plan.
For the latest updates regarding this recall and to view the official FDA release, owners should visit the FDA Safety Alerts portal.
